{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T11:26:44Z","timestamp":1778585204688,"version":"3.51.4"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,8,19]],"date-time":"2022-08-19T00:00:00Z","timestamp":1660867200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,8,19]],"date-time":"2022-08-19T00:00:00Z","timestamp":1660867200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"the science and technology commission of shanghai municipality","award":["18401970500"],"award-info":[{"award-number":["18401970500"]}]},{"DOI":"10.13039\/501100007279","name":"shanghai municipal health bureau","doi-asserted-by":"publisher","award":["Shxxjcxk201709"],"award-info":[{"award-number":["Shxxjcxk201709"]}],"id":[{"id":"10.13039\/501100007279","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007279","name":"shanghai municipal health bureau","doi-asserted-by":"publisher","award":["ZY (2018-2020)-CCCX-1006"],"award-info":[{"award-number":["ZY (2018-2020)-CCCX-1006"]}],"id":[{"id":"10.13039\/501100007279","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Trials"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>There has been a rapid increase in the worldwide prevalence of Alzheimer\u2019s disease (AD). Previous studies have shown that acupuncture can improve neurological and cognitive function; however, the utility of applying acupuncture in patients with AD remains unclear. This study protocol describes a clinical trial for evaluating the efficacy and safety of acupuncture based on syndrome differentiation with donepezil hydrochloride on cognitive function in patients with AD.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods\/design<\/jats:title>\n                <jats:p>This multicenter randomized controlled trial commenced on February 1, 2019, at the Shanghai Longhua Hospital of TCM, Shanghai Huashan Hospital of Fudan University, and Shanghai Mental Health Center, and will conclude on June 30, 2022. The study will recruit 184 patients randomly divided into an acupuncture group or a control group at a 1:1 ratio. All participants will receive donepezil hydrochloride (5 mg\/day), and those in the acupuncture group will receive acupuncture based on syndrome differentiation with donepezil for 12 weeks. The primary outcome will be the post-treatment change in the Alzheimer\u2019s Disease Assessment Scale-cognition score at 12 weeks. The secondary outcomes will be the efficacy scores of the Minimum Mental State Examination, Alzheimer\u2019s Disease Cooperative Research Activity-Daily Life, and Quality of Life-Alzheimer\u2019s Disease. All assessments will be performed at baseline, after treatment (week 12), and at follow-up (weeks 24 and 36).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Discussion<\/jats:title>\n                <jats:p>This trial may provide high-quality evidence for the efficacy of acupuncture in the treatment of AD. The results of this study will be published in peer-reviewed journals.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Trial registration<\/jats:title>\n                <jats:p><jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/clinicaltrials.gov\">ClinicalTrials.gov<\/jats:ext-link><jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/clinicaltrials.gov\/ct2\/show\/NCT03810794\">NCT03810794<\/jats:ext-link>. Registered on 17 January 2019.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13063-022-06532-1","type":"journal-article","created":{"date-parts":[[2022,8,19]],"date-time":"2022-08-19T11:04:34Z","timestamp":1660907074000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Effect of acupuncture with donepezil based on syndrome differentiation on cognitive function in patients with mild-to-moderate Alzheimer\u2019s disease: a study protocol for a multicenter randomized controlled trial"],"prefix":"10.1186","volume":"23","author":[{"given":"Qin-Hui","family":"Fu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6755-4380","authenticated-orcid":false,"given":"Jian","family":"Pei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hou-guang","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi-jun","family":"Zhan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lin","family":"Tao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jia","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qian","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liao-yao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,8,19]]},"reference":[{"issue":"10159","key":"6532_CR1","doi-asserted-by":"publisher","first-page":"1789","DOI":"10.1016\/S0140-6736(18)32279-7","volume":"392","author":"GBD 2017 Disease and Injury Incidence and Prevalence Collaborators","year":"2018","unstructured":"GBD 2017 Disease and Injury Incidence and Prevalence Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2018;392(10159):1789\u2013858. https:\/\/doi.org\/10.1016\/S0140-6736(18)32279-7.","journal-title":"Lancet"},{"key":"6532_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jalz.2013.01.012","volume":"10","author":"J Jia","year":"2014","unstructured":"Jia J, Wang F, Wei C, Zhou A, Jia X, Li F, et al. The prevalence of dementia in urban and rural areas of China. Alzheimers Dement. 2014;10:1\u20139. https:\/\/doi.org\/10.1016\/j.jalz.2013.01.012.","journal-title":"Alzheimers Dement"},{"key":"6532_CR3","doi-asserted-by":"publisher","first-page":"1859","DOI":"10.1016\/S0140-6736(18)32335-3","volume":"392","author":"GBD 2017 DALYs and HALE Collaborators","year":"2018","unstructured":"GBD 2017 DALYs and HALE Collaborators. Global, regional, and national disability-adjusted life-years (DALYs) for 359 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2018;392:1859\u2013922. https:\/\/doi.org\/10.1016\/S0140-6736(18)32335-3.","journal-title":"Lancet"},{"key":"6532_CR4","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1016\/j.jalz.2017.12.006","volume":"14","author":"J Jia","year":"2018","unstructured":"Jia J, Wei C, Chen S, Li F, Tang Y, Qin W, et al. The cost of Alzheimer's disease in China and re-estimation of costs worldwide. Alzheimers Dement. 2018;14:483\u201391. https:\/\/doi.org\/10.1016\/j.jalz.2017.12.006.","journal-title":"Alzheimers Dement"},{"issue":"Pt B","key":"6532_CR5","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.arr.2015.08.003","volume":"24","author":"EF Fang","year":"2015","unstructured":"Fang EF, Scheibye-Knudsen M, Jahn HJ, Li J, Ling L, Guo H, et al. A research agenda for aging in China in the 21st century. Ageing Res Rev. 2015;24(Pt B):197\u2013205. https:\/\/doi.org\/10.1016\/j.arr.2015.08.003.","journal-title":"Ageing Res Rev"},{"issue":"3","key":"6532_CR6","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1016\/j.jalz.2015.02.011","volume":"12","author":"J Yuan","year":"2016","unstructured":"Yuan J, Zhang Z, Wen H, Hong X, Hong Z, Qu Q, et al. Incidence of dementia and subtypes: A cohort study in four regions in China. Alzheimers Dement. 2016;12(3):262\u201371. https:\/\/doi.org\/10.1016\/j.jalz.2015.02.011.","journal-title":"Alzheimers Dement"},{"issue":"6","key":"6532_CR7","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1016\/S1474-4422(14)70090-0","volume":"13","author":"B Dubois","year":"2014","unstructured":"Dubois B, Feldman HH, Jacova C, Hampel H, Molinuevo JL, Blennow K, et al. Advancing research diagnostic criteria for Alzheimer's disease: the IWG-2 criteria. Lancet Neurol. 2014;13(6):614\u201329. https:\/\/doi.org\/10.1016\/S1474-4422(14)70090-0.","journal-title":"Lancet Neurol"},{"issue":"s1","key":"6532_CR8","doi-asserted-by":"publisher","first-page":"S47","DOI":"10.3233\/JAD-179932","volume":"64","author":"H Hampel","year":"2018","unstructured":"Hampel H, Toschi N, Babiloni C, Baldacci F, Black KL, Bokde ALW, et al. Revolution of Alzheimer Precision Neurology. Passageway of Systems Biology and Neurophysiology. J Alzheimers Dis. 2018;64(s1):S47\u2013S105. https:\/\/doi.org\/10.3233\/JAD-179932.","journal-title":"J Alzheimers Dis"},{"issue":"Pt 5","key":"6532_CR9","doi-asserted-by":"publisher","first-page":"1551","DOI":"10.1093\/brain\/aww027","volume":"139","author":"R Ossenkoppele","year":"2016","unstructured":"Ossenkoppele R, Schonhaut DR, Sch\u00f6ll M, Lockhart SN, Ayakta N, Baker SL, et al. Tau PET patterns mirror clinical and neuroanatomical variability in Alzheimer's disease. Brain. 2016;139(Pt 5):1551\u201367. https:\/\/doi.org\/10.1093\/brain\/aww027.","journal-title":"Brain."},{"key":"6532_CR10","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1136\/bmj.331.7512.321","volume":"331","author":"H Kaduszkiewicz","year":"2005","unstructured":"Kaduszkiewicz H, Zimmermann T, Beck-Bornholdt HP, van den Bussche H. Cholinesterase inhibitors for patients with Alzheimer\u2019s disease: systematic review of randomised clinical trials. BMJ. 2005;331:321\u20137. https:\/\/doi.org\/10.1136\/bmj.331.7512.321.","journal-title":"BMJ."},{"key":"6532_CR11","doi-asserted-by":"publisher","first-page":"2269","DOI":"10.1212\/wnl.54.12.2269","volume":"54","author":"PN Tariot","year":"2000","unstructured":"Tariot PN, Solomon PR, Morris JC, Kershaw P, Lilienfield S, Ding C. A 5-month, randomized, placebo-controlled trial of galantamine in AD. The Galantamine USA-10 Study Group. Neurology. 2000;54:2269\u201376. https:\/\/doi.org\/10.1212\/wnl.54.12.2269.","journal-title":"Neurology."},{"key":"6532_CR12","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.archger.2009.11.004","volume":"52","author":"JL Molinuevo","year":"2011","unstructured":"Molinuevo JL, Berthier ML, Rami L. Donepezil provides greater benefits in mild compared to moderate Alzheimer's disease: implications for early diagnosis and treatment. Arch Gerontol Geriatr. 2011;52:18\u201322. https:\/\/doi.org\/10.1016\/j.archger.2009.11.004.","journal-title":"Arch Gerontol Geriatr"},{"key":"6532_CR13","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1503\/cmaj.051432","volume":"174","author":"K Rockwood","year":"2006","unstructured":"Rockwood K. Attainment of treatment goals by people with Alzheimer\u2019s disease receiving galantamine: a randomized controlled trial. CMAJ. 2006;174:1099\u2013105. https:\/\/doi.org\/10.1503\/cmaj.051432.","journal-title":"CMAJ."},{"key":"6532_CR14","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1001\/jama.291.3.317","volume":"291","author":"PN Tariot","year":"2004","unstructured":"Tariot PN, Farlow MR, Grossberg GT, Graham SM, McDonald S, Gergel I. Memantine treatment in patients with moderate to severe Alzheimer disease already receiving donepezil: a randomized controlled trial. JAMA. 2004;291:317\u201324. https:\/\/doi.org\/10.1001\/jama.291.3.317.","journal-title":"JAMA."},{"key":"6532_CR15","doi-asserted-by":"publisher","first-page":"CD001190","DOI":"10.1002\/14651858.CD001190.pub3","volume":"6","author":"JS Birks","year":"2018","unstructured":"Birks JS, Harvey RJ. Donepezil for dementia due to Alzheimer\u2019s disease. Cochrane Database Syst Rev. 2018;6:CD001190. https:\/\/doi.org\/10.1002\/14651858.CD001190.pub3.","journal-title":"Cochrane Database Syst Rev"},{"issue":"2","key":"6532_CR16","first-page":"211","volume":"3","author":"R Hansen","year":"2008","unstructured":"Hansen R, Gartlehner G, Webb PA. Efficacy and safety of donepezil, galantamine, and rivastigmine for the treatment of Alzheimer\u2019s disease: a systematic review and meta-analysis. Clin Interv Aging. 2008;3(2):211\u201325 PMID: 18686744.","journal-title":"Clin Interv Aging"},{"key":"6532_CR17","doi-asserted-by":"publisher","first-page":"245","DOI":"10.2147\/nedt.2007.3.2.245","volume":"3","author":"RR Tampi","year":"2007","unstructured":"Tampi RR, Dyck CH. Memantine: efficacy and safety in mild-to-severe Alzheimer\u2019s disease. Neuropsychiatr Dis Treat. 2007;3:245\u201358. https:\/\/doi.org\/10.2147\/nedt.2007.3.2.245.","journal-title":"Neuropsychiatr Dis Treat"},{"key":"6532_CR18","doi-asserted-by":"publisher","first-page":"594432","DOI":"10.3389\/fnagi.2020.594432","volume":"12","author":"L Wang","year":"2020","unstructured":"Wang L, Pei J, Zhan Y, Cai Y. Overview of Meta-Analyses of Five Non-pharmacological Interventions for Alzheimer\u2019s Disease. Front Aging Neurosci. 2020;12:594432. https:\/\/doi.org\/10.3389\/fnagi.2020.594432.","journal-title":"Front Aging Neurosci"},{"key":"6532_CR19","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1038\/mp.2012.162","volume":"18","author":"BM Brown","year":"2013","unstructured":"Brown BM, Peiffer JJ, Martins RN. Multiple effects of physical activity on molecular and cognitive signs of brain aging: can exercise slow neurodegeneration and delay Alzheimer\u2019s disease? Mol Psychiatry. 2013;18:864\u201374. https:\/\/doi.org\/10.1038\/mp.2012.162.","journal-title":"Mol Psychiatry"},{"key":"6532_CR20","doi-asserted-by":"publisher","first-page":"e933","DOI":"10.1097\/MD.0000000000000933","volume":"94","author":"J Zhou","year":"2015","unstructured":"Zhou J, Peng WN, Xu M, Li W, Liu ZS. The effectiveness and safety of acupuncture for patients with Alzheimer disease: a systematic review and meta-analysis of randomized controlled trials. Medicine (Baltimore). 2015;94:e933. https:\/\/doi.org\/10.1097\/MD.0000000000000933.","journal-title":"Medicine (Baltimore)"},{"key":"6532_CR21","doi-asserted-by":"publisher","first-page":"574","DOI":"10.2174\/1568026615666150813144942","volume":"16","author":"Y Cao","year":"2016","unstructured":"Cao Y, Zhang LW, Wang J, Du SQ, Xiao LY, Tu JF, et al. Mechanisms of acupuncture effect on Alzheimer\u2019s disease in animal- based researches. Curr Top Med Chem. 2016;16:574\u20138. https:\/\/doi.org\/10.2174\/1568026615666150813144942.","journal-title":"Curr Top Med Chem"},{"key":"6532_CR22","doi-asserted-by":"publisher","first-page":"250","DOI":"10.4103\/1673-5374.200808","volume":"12","author":"TT Tan","year":"2017","unstructured":"Tan TT, Wang D, Huang JK, Zhou XM, Yuan X, Liang JP, et al. Modulatory effects of acupuncture on brain networks in mild cognitive impairment patients. Neural Regen Res. 2017;12:250\u20138. https:\/\/doi.org\/10.4103\/1673-5374.200808.","journal-title":"Neural Regen Res"},{"key":"6532_CR23","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1002\/nur.21738","volume":"39","author":"H Zeng","year":"2016","unstructured":"Zeng H, Liu M, Wang P, Kang J, Lu F, Pan L. The effects of acupressure training on sleep quality and cognitive function of older adults: a 1-year randomized controlled trial. Res Nurs Health. 2016;39:328\u201336. https:\/\/doi.org\/10.1002\/nur.21738.","journal-title":"Res Nurs Health"},{"key":"6532_CR24","doi-asserted-by":"publisher","first-page":"389","DOI":"10.3233\/JAD-170477","volume":"60","author":"J Tao","year":"2017","unstructured":"Tao J, Liu J, Liu W, Huang J, Xue X, Chen X, et al. Tai Chi Chuan and Baduanjin increase grey matter volume in older adults: a brain imaging study. J Alzheimers Dis. 2017;60:389\u2013400. https:\/\/doi.org\/10.3233\/JAD-170477.","journal-title":"J Alzheimers Dis"},{"key":"6532_CR25","doi-asserted-by":"publisher","first-page":"e114057","DOI":"10.1371\/journal.pone.0114057","volume":"9","author":"L Li","year":"2014","unstructured":"Li L, Zhang H, Meng SQ, Qian HZ. An updated meta-analysis of the efficacy and safety of acupuncture treatment for cerebral infarction. PLoS One. 2014;9:e114057. https:\/\/doi.org\/10.1371\/journal.pone.0114057.","journal-title":"PLoS One"},{"key":"6532_CR26","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1111\/ner.12724","volume":"21","author":"LY Xiao","year":"2018","unstructured":"Xiao LY, Wang XR, Yang Y, Yang JW, Cao Y, Ma SM, et al. Applications of Acupuncture Therapy in Modulating Plasticity of Central Nervous System. Neuromodulation. 2018;21:762\u201376. https:\/\/doi.org\/10.1111\/ner.12724.","journal-title":"Neuromodulation."},{"key":"6532_CR27","doi-asserted-by":"publisher","unstructured":"Feng Q, Bin LL, ZhaiYB XM, Liu ZS, Peng WN. Long-term efficacy and safety of electroacupuncture on improving MMSE in patients with Alzheimer\u2019s disease. Zhongguo Zhen Jiu. 2019;39(3-8). https:\/\/doi.org\/10.13703\/j.0255-2930.2019.01.001 (in Chinese).","DOI":"10.13703\/j.0255-2930.2019.01.001"},{"issue":"2","key":"6532_CR28","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/S1003-5257(14)60020-9","volume":"24","author":"Y Wang","year":"2014","unstructured":"Wang Y, Qin WG, Yu CD. Clinical observation on effect of cranial suture acupuncture combined with donepezil hydrochloride tablets for Alzheimer\u2019s disease. World J Acupunct Moxibustion. 2014;24(2):19\u201324. https:\/\/doi.org\/10.1016\/S1003-5257(14)60020-9.","journal-title":"World J Acupunct Moxibustion"},{"issue":"6","key":"6532_CR29","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1089\/acu.2021.0014","volume":"33","author":"Y Teja","year":"2021","unstructured":"Teja Y, Helianthi DR, Nareswari I. The Role of Medical Acupuncture Therapy in Alzheimer\u2019s Disease. Med Acupunct. 2021;33(6):396\u2013402. https:\/\/doi.org\/10.1089\/acu.2021.0014.","journal-title":"Med Acupunct"},{"key":"6532_CR30","doi-asserted-by":"publisher","first-page":"2823679","DOI":"10.1155\/2019\/2823679","volume":"2019","author":"Y Tang","year":"2019","unstructured":"Tang Y, Shao S, Guo Y, Zhou Y, Cao J, Xu A, et al. Electroacupuncture mitigates hippocampal cognitive impairments by reducing BACE1 deposition and activating PKA in APP\/PS1 double transgenic mice. Neural Plast. 2019;2019:2823679. https:\/\/doi.org\/10.1155\/2019\/2823679.","journal-title":"Neural Plast"},{"key":"6532_CR31","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/1472-6882-14-37","volume":"14","author":"X Li","year":"2014","unstructured":"Li X, Guo F, Zhang Q, Huo T, Liu L, Wei H, et al. Electro-acupuncture decreases cognitive impairment and promotes neurogenesis in the APP\/PS1 transgenic mice. BMC Complement Altern Med. 2014;14:37. https:\/\/doi.org\/10.1186\/1472-6882-14-37.","journal-title":"BMC Complement Altern Med"},{"key":"6532_CR32","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.neulet.2007.12.009","volume":"432","author":"H Cheng","year":"2008","unstructured":"Cheng H, Yu J, Jiang Z, Zhang X, Liu C, Peng Y, et al. Acupuncture improves cognitive deficits and regulates the brain cell proliferation of SAMP8 mice. Neurosci Lett. 2008;432:111\u20136. https:\/\/doi.org\/10.1016\/j.neulet.2007.12.009.","journal-title":"Neurosci Lett"},{"key":"6532_CR33","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1007\/s11011-014-9641-1","volume":"30","author":"W Dong","year":"2015","unstructured":"Dong W, Guo W, Zheng X, Wang F, Chen Y, Zhang W, et al. Electro-acupuncture improves cognitive deficits associated with AMPK activation in SAMP8 mice. Metab Brain Dis. 2015;30:777\u201384. https:\/\/doi.org\/10.1007\/s11011-014-9641-1.","journal-title":"Metab Brain Dis"},{"key":"6532_CR34","doi-asserted-by":"publisher","first-page":"393569","DOI":"10.1155\/2015\/393569","volume":"2015","author":"HD Guo","year":"2015","unstructured":"Guo HD, Tian JX, Zhu J, Li L, Sun K, Shao SJ, et al. Electroacupuncture Suppressed Neuronal Apoptosis and Improved Cognitive Impairment in the AD Model Rats Possibly via Downregulation of Notch Signaling Pathway. Evid Based Complement Alternat Med. 2015;2015:393569. https:\/\/doi.org\/10.1155\/2015\/393569.","journal-title":"Evid Based Complement Alternat Med"},{"key":"6532_CR35","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1186\/1472-6882-14-178","volume":"14","author":"Y Lu","year":"2014","unstructured":"Lu Y, Huang Y, TangC SB, Cui S, Yang J, et al. Brain areas involved in the acupuncture treatment of AD model rats: a PET study. BMC Complement Altern Med. 2014;14:178. https:\/\/doi.org\/10.1186\/1472-6882-14-178.","journal-title":"BMC Complement Altern Med"},{"key":"6532_CR36","doi-asserted-by":"publisher","first-page":"8740284","DOI":"10.1155\/2018\/8740284","volume":"2018","author":"SY Cui","year":"2018","unstructured":"Cui SY, Xu MZ, Huang JT, Wang QM, Lai X, Nie B, et al. Cerebral Responses to Acupuncture at GV24 and Bilateral GB13 in Rat Models of Alzheimer's Disease. Behav Neurol. 2018;2018:8740284. https:\/\/doi.org\/10.1155\/2018\/8740284.","journal-title":"Behav Neurol"},{"issue":"12","key":"6532_CR37","doi-asserted-by":"publisher","first-page":"91","DOI":"10.16305\/j.1007-1334.2020.2003339","volume":"54","author":"Q Zhou","year":"2020","unstructured":"Zhou Q, Fu QH, Pei J. Research progress on diagnostic criteria of TCM syndromes in Alzheimer's disease. Shanghai J Tradit Chin Med. 2020;54(12):91\u20136. https:\/\/doi.org\/10.16305\/j.1007-1334.2020.2003339 in Chinese.","journal-title":"Shanghai J Tradit Chin Med"},{"key":"6532_CR38","doi-asserted-by":"publisher","first-page":"22","DOI":"10.16305\/j.1007-1334.2011.09.010","volume":"45","author":"J Wang","year":"2011","unstructured":"Wang J, Lin SM. Considerations on simultaneous treatment of heart-kidney in Alzheimer\u2019s disease. Shanghai J Tradit Chin Med. 2011;45:22\u20133. https:\/\/doi.org\/10.16305\/j.1007-1334.2011.09.010 in Chinese.","journal-title":"Shanghai J Tradit Chin Med"},{"key":"6532_CR39","doi-asserted-by":"publisher","first-page":"e7586","DOI":"10.1136\/bmj.e7586","volume":"346","author":"A-W Chan","year":"2013","unstructured":"Chan A-W, Tetzlaff JM, G\u00f8tzsche PC, Altman DG, Mann H, Berlin J, et al. SPIRIT 2013 Explanation and Elaboration: Guidance for protocols of clinical trials. BMJ. 2013;346:e7586. https:\/\/doi.org\/10.1136\/bmj.e7586.","journal-title":"BMJ."},{"key":"6532_CR40","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1016\/S1474-4422(07)70178-3","volume":"6","author":"B Dubois","year":"2007","unstructured":"Dubois B, Feldman HH, Jacova C, Dekosky ST, Barberger-Gateau P, Cummings J, et al. Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS-ADRDA criteria. Lancet Neurol. 2007;6:734\u201346. https:\/\/doi.org\/10.1016\/S1474-4422(07)70178-3.","journal-title":"Lancet Neurol"},{"issue":"7","key":"6532_CR41","doi-asserted-by":"publisher","first-page":"766","DOI":"10.3736\/jcim20120707","volume":"10","author":"L Yu","year":"2012","unstructured":"Yu L, Lin SM, Zhou RQ, Tang WJ, Huang PX, Dong Y, et al. Chinese herbal medicine for patients with mild to moderate Alzheimer disease based on syndrome differentiation: a randomized controlled trial. J Chin Integr Med. 2012;10(7):766\u201376. https:\/\/doi.org\/10.3736\/jcim20120707.","journal-title":"J Chin Integr Med"},{"key":"6532_CR42","doi-asserted-by":"publisher","first-page":"1356","DOI":"10.1176\/ajp.141.11.1356","volume":"141","author":"WG Rosen","year":"1984","unstructured":"Rosen WG, Mohs RC, Davis KL. A new rating scale for Alzheimer's disease. Am J Psychiatry. 1984;141:1356\u201364. https:\/\/doi.org\/10.1176\/ajp.141.11.1356.","journal-title":"Am J Psychiatry"},{"key":"6532_CR43","first-page":"231","volume":"18","author":"H Wang","year":"2004","unstructured":"Wang H, Yu X, Li S, Chen Y, Li H, He J. The cognitive subscale of Alzheimer\u2019s Disease Assessment Scale, Chinese version in staging of Alzheimer disease. Alzheimer DisAssocDisord. 2004;18:231\u20135 PMID: 15592136.","journal-title":"Alzheimer DisAssocDisord"},{"key":"6532_CR44","first-page":"627","volume":"24","author":"RC Mohs","year":"1988","unstructured":"Mohs RC, Cohen L. Alzheimer\u2019s Disease Assessment Scale (ADAS). Psychopharmacol Bull. 1988;24:627\u20138 PMID: 3249763.","journal-title":"Psychopharmacol Bull"},{"key":"6532_CR45","doi-asserted-by":"publisher","first-page":"S33","DOI":"10.1097\/00002093-199700112-00005","volume":"11","author":"D Galasko","year":"1997","unstructured":"Galasko D, Bennett D, Sano M, Ernesto C, Thomas R, Grundman M, et al. An inventory to assess activities of daily living for clinical trials in Alzheimer\u2019s Disease. Alzheimer Dis Assoc Disord. 1997;11:S33\u20139. https:\/\/doi.org\/10.1097\/00002093-199700112-00005.","journal-title":"Alzheimer Dis Assoc Disord"},{"key":"6532_CR46","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/0022-3956(75)90026-6","volume":"12","author":"MF Folstein","year":"1975","unstructured":"Folstein MF, Folstein SE, McHugh PR. \u201cMini-mental state\u201d: a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975;12:189\u201398. https:\/\/doi.org\/10.1016\/0022-3956(75)90026-6.","journal-title":"J Psychiatr Res"},{"key":"6532_CR47","first-page":"21","volume":"5","author":"RG Logsdon","year":"1999","unstructured":"Logsdon RG, Gibbons LE, McCurry SM, Teri L. Quality of life in Alzheimer\u2019s disease: patient and caregiver reports. J Mental Health Aging. 1999;5:21\u201332 https:\/\/www.researchgate.net\/publication\/232417911.","journal-title":"J Mental Health Aging"},{"key":"6532_CR48","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1097\/00006842-200205000-00016","volume":"64","author":"RG Logsdon","year":"2002","unstructured":"Logsdon RG, Gibbons LE, McCurry SM, Teri L. Assessing quality of life in older adults with cognitive impairment. Psychosom Med. 2002;64:510\u20139. https:\/\/doi.org\/10.1097\/00006842-200205000-00016.","journal-title":"Psychosom Med"},{"issue":"01","key":"6532_CR49","doi-asserted-by":"publisher","first-page":"19","DOI":"10.16305\/j.1007-1334.2019.01.005","volume":"53","author":"YS Wang","year":"2019","unstructured":"Wang YS, Xu J, Fu QH, Pei J. Acupuncture combined with medicine for cognitive functions and life quality of patients with Alzheimer\u2019 s disease: a systematic review. Shanghai J Tradit Chin Med. 2019;53(01):19\u201325. https:\/\/doi.org\/10.16305\/j.1007-1334.2019.01.005.","journal-title":"Shanghai J Tradit Chin Med"},{"key":"6532_CR50","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1186\/s12906-017-2064-x","volume":"17","author":"Y Jia","year":"2017","unstructured":"Jia Y, Zhang X, Yu J, Han J, Yu T, Shi J, et al. Acupuncture for patients with mild to moderate Alzheimer's disease: a randomized controlled trial. BMC Complement Altern Med. 2017;17:556. https:\/\/doi.org\/10.1186\/s12906-017-2064-x.","journal-title":"BMC Complement Altern Med"},{"issue":"8","key":"6532_CR51","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1007\/s11655-019-3066-y","volume":"25","author":"JZ Tian","year":"2019","unstructured":"Tian JZ, Shi J, Ni JN, Wei MQ, Zhang XK, Chen KJ, et al. Sequential Therapy Based on Evolvement of Patterns: A New Model for Treatment of Alzheimer's Disease. Chin J Integr Med. 2019;25(8):565\u201373. https:\/\/doi.org\/10.1007\/s11655-019-3066-y.","journal-title":"Chin J Integr Med"}],"container-title":["Trials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-022-06532-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13063-022-06532-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-022-06532-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,19]],"date-time":"2022-08-19T11:22:42Z","timestamp":1660908162000},"score":1,"resource":{"primary":{"URL":"https:\/\/trialsjournal.biomedcentral.com\/articles\/10.1186\/s13063-022-06532-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,19]]},"references-count":51,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["6532"],"URL":"https:\/\/doi.org\/10.1186\/s13063-022-06532-1","relation":{},"ISSN":["1745-6215"],"issn-type":[{"value":"1745-6215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,19]]},"assertion":[{"value":"18 July 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 July 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 August 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study protocol and research consent were approved by the Longhua Hospital Ethics Review Committee (number 2018LCSY060). In the case of any changes to the study protocol, we will submit a written application form to the Research Ethics Committee. They will decide whether or not it is necessary to change the study protocol. The Research Ethics Committee will supervise all procedures of the study. The purpose and risks of the trial will be explained in detail to the participants, who will be required to write informed consent to indicate that they agree with the protocol and would participate in the trial. The participants will be able to quit at any time during the study period.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"695"}}